OBJECTIVE: A systematic review and meta-analysis was conducted to illustrate whether people with multiple sclerosis engage in more physical activity following behaviour change interventions. DATA RESOURCES: MEDLINE, CINAHL, PubMed, Web of Sciences, Cochrane Library, SCOPUS, EMBASE and PEDro were searched from their inception till 30 April 2015. TRIAL SELECTION: Randomized and clinical controlled trials that used behaviour change interventions to increase physical activity in people with multiple sclerosis were selected, regardless of type or duration of multiple sclerosis or disability severity. DATA EXTRACTION: Data extraction was conducted by two independent reviewers and the Cochrane Collaboration's recommended method was used to assess the risk of bias of each included study. RESULTS: A total of 19 out of 573 studies were included. Focusing on trials without risk of bias, meta-analysis showed that behaviour change interventions can significantly increase physical activity participation (z = 2.20, p = 0.03, standardised main difference 0.65, 95% confidence interval 0.07 to 1.22, 3 trials, I(2) = 68%) (eight to 12 weeks' duration). Behaviour change interventions did not significantly impact on the physical components of quality of life or fatigue. CONCLUSION: Behaviour change interventions provided for relatively short duration (eight to 12 weeks) may increase the amount of physical activity people with multiple sclerosis engage in, but appear to have no effect on the physical components of quality of life and fatigue. Further high quality investigations of the efficacy of behaviour change interventions to increase physical activity participation that focus on dose, long-term impact and method of delivery are warranted for people with multiple sclerosis.
OBJECTIVE: A systematic review and meta-analysis was conducted to illustrate whether people with multiple sclerosis engage in more physical activity following behaviour change interventions. DATA RESOURCES: MEDLINE, CINAHL, PubMed, Web of Sciences, Cochrane Library, SCOPUS, EMBASE and PEDro were searched from their inception till 30 April 2015. TRIAL SELECTION: Randomized and clinical controlled trials that used behaviour change interventions to increase physical activity in people with multiple sclerosis were selected, regardless of type or duration of multiple sclerosis or disability severity. DATA EXTRACTION: Data extraction was conducted by two independent reviewers and the Cochrane Collaboration's recommended method was used to assess the risk of bias of each included study. RESULTS: A total of 19 out of 573 studies were included. Focusing on trials without risk of bias, meta-analysis showed that behaviour change interventions can significantly increase physical activity participation (z = 2.20, p = 0.03, standardised main difference 0.65, 95% confidence interval 0.07 to 1.22, 3 trials, I(2) = 68%) (eight to 12 weeks' duration). Behaviour change interventions did not significantly impact on the physical components of quality of life or fatigue. CONCLUSION: Behaviour change interventions provided for relatively short duration (eight to 12 weeks) may increase the amount of physical activity people with multiple sclerosis engage in, but appear to have no effect on the physical components of quality of life and fatigue. Further high quality investigations of the efficacy of behaviour change interventions to increase physical activity participation that focus on dose, long-term impact and method of delivery are warranted for people with multiple sclerosis.
Authors: Julie Latchem-Hastings; Elizabeth Randell; Kate Button; Fiona Jones; Rachel Lowe; Helen Dawes; Fiona Wood; Freya Davies; Vincent Poile; Rhian O'Halloran; Barbara Stensland; Emma Tallantyre; Rebecca Playle; Adrian Edwards; Monica Busse Journal: Pilot Feasibility Stud Date: 2021-05-22
Authors: Stephanie L Silveira; Trinh Huynh; Ariel Kidwell; Dena Sadeghi-Bahmani; Robert W Motl Journal: Arch Phys Med Rehabil Date: 2021-02-05 Impact factor: 4.060
Authors: Martin Heine; Olaf Verschuren; Erwin Lj Hoogervorst; Erik van Munster; Hub Ga Hacking; Anne Visser-Meily; Jos Wr Twisk; Heleen Beckerman; Vincent de Groot; Gert Kwakkel Journal: Mult Scler Date: 2017-05-22 Impact factor: 6.312
Authors: Sarah Thomas; Louise Fazakarley; Peter W Thomas; Sarah Collyer; Sarah Brenton; Steve Perring; Rebecca Scott; Fern Thomas; Charlotte Thomas; Kelly Jones; Jo Hickson; Charles Hillier Journal: BMJ Open Date: 2017-09-27 Impact factor: 2.692
Authors: Yvonne C Learmonth; Brynn C Adamson; Julia M Balto; Chung-Yi Chiu; Isabel Molina-Guzman; Marcia Finlayson; Barry J Riskin; Robert W Motl Journal: Health Expect Date: 2016-07-20 Impact factor: 3.377
Authors: Monica Busse; Julie Latchem-Hastings; Kate Button; Vince Poile; Freya Davies; Rhian O' Halloran; Barbara Stensland; Emma Tallantyre; Rachel Lowe; Fiona Wood; Helen Dawes; Adrian Edwards; Fiona Jones Journal: BMJ Open Date: 2021-03-16 Impact factor: 2.692
Authors: Jennifer Fortune; Meriel Norris; Andrea Stennett; Cherry Kilbride; Grace Lavelle; Wendy Hendrie; Lorraine de Souza; Mohamed Abdul; Debbie Brewin; Lee David; Nana Anokye; Christina Victor; Jennifer M Ryan Journal: BMJ Open Date: 2020-03-06 Impact factor: 2.692
Authors: Farren L Goulding; Charity D Evans; Katherine B Knox; Hyun J Lim; Michael C Levin; Sarah J Donkers Journal: Trials Date: 2019-12-02 Impact factor: 2.279